Tangier disease: still more questions than answers

Area of Science:

• Biochemistry
• Genetics
• Cardiovascular Science

Background:

• High-density lipoproteins (HDL) are crucial for reverse cholesterol transport, moving cholesterol from tissues to the liver.
• Impaired HDL function contributes to cholesterol accumulation in arteries, promoting atherosclerosis.
• Tangier disease, a severe HDL deficiency, involves cholesterol-laden macrophages and significant atherosclerosis.

Purpose of the Study:

• To identify the genetic cause of Tangier disease.
• To understand the role of the identified gene in HDL metabolism and cholesterol transport.
• To explore the therapeutic potential of targeting this gene for cardiovascular disease prevention.

Main Methods:

• A multi-decade genetic investigation was conducted to find the gene responsible for Tangier disease.
• Functional studies were performed to elucidate the role of the identified protein in cellular cholesterol efflux.
• Analysis of plasma HDL levels and cholesterol deposition in affected individuals.

Main Results:

• Mutations in the ABCA1 gene were identified as the cause of Tangier disease.
• ABCA1 protein was found to mediate the secretion of excess cholesterol from cells into the HDL pathway.
• ABCA1's role in cholesterol depletion from cells and increasing HDL levels was confirmed.

Conclusions:

• ABCA1 is essential for normal HDL metabolism and cholesterol homeostasis.
• ABCA1 mutations lead to severe HDL deficiency, cholesterol accumulation, and atherosclerosis.
• Targeting ABCA1 presents a promising therapeutic strategy for cardiovascular disease prevention.